Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISE sciatica trial of pregabalin plus usual care versus placebo plus usual care
ACTRN12613000530729Phase 4Completed
- Sponsor
- The George Institute for Global Health
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pregabalin in Sciatica, sponsored by The George Institute for Global Health. Primary endpoint: Average leg pain intensity over the last 24 hours at week 52. Started Sep 2013; status: completed.
02
Drugs
pregabalin
03
Conditions
Sciatica
Beyond the preview
Go deeper on ACTRN12613000530729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000530729.